Wiley Bros. Aintree Capital, LLC Bio Rad Laboratories, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 1,574 shares of BIO stock, worth $495,385. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,574Holding current value
$495,385% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BIO
# of Institutions
467Shares Held
18.8MCall Options Held
19.5KPut Options Held
13.9K-
Vanguard Group Inc Valley Forge, PA1.92MShares$604 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$488 Million0.01% of portfolio
-
Wealthfront Advisers LLC1.04MShares$328 Million0.29% of portfolio
-
Veritas Asset Management LLP977KShares$307 Million3.36% of portfolio
-
Van Eck Associates Corp723KShares$228 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.75B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...